Presto Technologies (NASDAQ:PRST) reported quarterly earnings of $0.71 per share. The company reported $7.80 million in sales this quarter.
“Rafael Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 17/261,237 Titled ‘Therapeutic Methods And Compositions For Treating Pancreatic Cancer Using 6,8-BIS-BENZYLTHIO-OCTANOIC ACID'” – USPTO
https://patentcenter.uspto.gov/#!/applications/17261237/ifw/docs
